Digital Therapeutics Strategic Partnerships Summit

Memo

Digital Therapeutics represents an opportunity to capitalize on technology and efficiency while delivering an elevated standard of care to patients. The innovation of digital therapeutics will enable the population to monitor and manage their healthcare as well as prevent diseases and improve their patient outcomes. This is a critical time for the industry as guidelines are put in place and best practices are being developed. In order to advance the industry, it is critical for digital therapeutics owners, healthcare providers, payers and pharmaceutical organizations to come together and create mutually beneficial partnerships.The Digital Therapeutics Strategic Partnerships Summit is designed to be a meeting of the stakeholders, featuring real case-studies and lessons learned, to foster collaboration and ensure a common goal is defined. The goal of this Summit is to provide tangible resources while discussing standards for regulatory pathways, the benefits of strategic partnerships, and the importance of data sharing and governance. The Summit will focus on collaborating, educating and strategizing as an industry. Join the speaking faculty as they dive deep and collaborate to detail tactical solutions and their lessons learned in strategic partnerships, commercial models, regulatory pathways and data standards. As innovative companies continue to pave the way in this industry, there are many strategies and topics to be discusses between the above-mentioned stakeholders, including: *Market Access*The New Commercial Model*Regulatory Pathways*Scalability Models*Partnership Opportunities and Strategies*Clinical Validation*Data Management and Communication Prices:Early Bird: USD 1895.0,Standard: USD 2095.0,Onsite: USD 2295.0 Speakers: Veera Anantha Founder, CTO and President, THE LEARNING CORP, Mark Bini Vice President, Innovation and Member Experience, EXPRESS SCRIPTS, Dave Conn COO, GLOOKO, Edward Cox CEO, DTHERA SCIENCES, Martin Culjat SVP Scientific and Regulatory Affairs, DTHERA SCIENCES, Mette Dyhrberg Founder and CEO, MYMEE, Barbara Eichorst Global Diabetes and Digital Therapeutics Clinical Liaison, VOLUNTIS , Laurel Fuqua Executive VP and Chief Clinical Officer, MONARCH MEDICAL TECHNOLOGIES, Alan Gilbert CEO, BECARELINK, Jennifer Goldsack Interim Executive Director, DIME SOCIETY, Vincent Hennemand SVP, Corporate and Business Development, AKILI INTERACTIVE LABS, Adam Kaufman President and CEO, CANARY HEALTH , Kevin McRaith CEO, WELLDOC, Debra Reisenthel Founding CEO, Freespira Digital Therapeutic, PALO ALTO HEALTH SCIENCES, Joel Sangerman Chief Commercial Officer, CLICK THERAPEUTICS, Ruchita Sinha Senior Director of Investments, SANOFI VENTURES, Ryan Sysko CEO, AMALGAMRX, Suzanne Sysko Clough, M.D. Chief Medical Officer, AMALGAMRX, Matthew Tucker Director of Strategy and Innovation, HIGHMARK HEALTH , Chris Wasden Ed.D., Head, Pharma, HAPPIFYDTX Venue details: Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, 90048, United States Time: 8:00 am - 5:00 pm